Onco-HEM SRL
Onco-HEM reported total assets of 511,591 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Sep 2026).
The score of Onco-HEM shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +41 % Total assets +43 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Onco-HEM's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 97,574 € | ||||
| Equity | 450,777 € | ||||
| Cash | 201,112 € | ||||
| EBITDA | 160,419 € | ||||
| Total assets | 511,591 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Sep 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Onco-HEM's financial analysis
- Solvency88.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Onco-HEM
Onco-HEM's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.730.371
- VAT number
- BE0862730371
- Peppol
- Registered · 0208:0862730371 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2004
- Registered office
- 7133 Binche
- Latest accounts
- 2025 · filed on 28 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Onco-HEM (SRL) has been based in Binche since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 97,574 € and equity of 450,777 €; its revenue is not published. Its solvency stands at 88.1%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Onco-HEM
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Mees Herk-de-Stad Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 511,428 €
- Pharmacie Gilissen Retail sale of pharmaceutical products Herstal · balance sheet 512,045 €
- Saussure Pharma Retail sale of pharmaceutical products Beauraing · balance sheet 509,667 €
- Wolfs Pharma Retail sale of pharmaceutical products Liège · balance sheet 509,540 €
- Almapharma Retail sale of pharmaceutical products De Panne · balance sheet 515,565 €
- Curepharma Retail sale of pharmaceutical products Antwerp · balance sheet 516,103 €
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
- Phaies Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 516,859 €
Frequently asked questions about Onco-HEM
What is the revenue of Onco-HEM?
Onco-HEM files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Onco-HEM?
In Belgium, the VAT number is the company number prefixed with BE: BE0862730371 for Onco-HEM, if the company is VAT-registered. Its company number (CBE) is 0862.730.371.
Where is the registered office of Onco-HEM?
According to the CBE register, the registered office of Onco-HEM is in 7133 Binche.
What is the equity of Onco-HEM?
At the close of the 2025 financial year, the equity of Onco-HEM amounts to 450,777 €, a solvency of 88.1% of total assets.
Who manages Onco-HEM?
The register lists 2 active mandates at Onco-HEM. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Onco-HEM
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →